PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 545.0
(-2.68%)
IDR 545.0
(-2.68%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1190.87 Billion IDR | -14.51% |
| 2022 | 1393.06 Billion IDR | -11.65% |
| 2021 | 1576.69 Billion IDR | 36.98% |
| 2020 | 1151.02 Billion IDR | 12.38% |
| 2019 | 1024.24 Billion IDR | 24.25% |
| 2018 | 824.33 Billion IDR | 28.75% |
| 2017 | 640.23 Billion IDR | 11.89% |
| 2016 | 572.19 Billion IDR | 2.13% |
| 2015 | 560.24 Billion IDR | 2.09% |
| 2014 | 548.77 Billion IDR | -15.61% |
| 2013 | 650.28 Billion IDR | 27.09% |
| 2012 | 511.68 Billion IDR | 12.95% |
| 2011 | 453.01 Billion IDR | 32.09% |
| 2010 | 342.96 Billion IDR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 209.69 Billion IDR | -13.33% |
| 2024 Q1 | 496.42 Billion IDR | 8.98% |
| 2024 Q2 | 251.44 Billion IDR | -49.35% |
| 2023 FY | 1190.87 Billion IDR | -14.51% |
| 2023 Q1 | 369.53 Billion IDR | -24.15% |
| 2023 Q2 | 193.32 Billion IDR | -47.68% |
| 2023 Q4 | 455.5 Billion IDR | 164.05% |
| 2023 Q3 | 172.5 Billion IDR | -10.77% |
| 2022 Q3 | 347.28 Billion IDR | 81.35% |
| 2022 Q1 | 367.11 Billion IDR | -26.31% |
| 2022 FY | 1393.06 Billion IDR | -11.65% |
| 2022 Q4 | 487.17 Billion IDR | 40.28% |
| 2022 Q2 | 191.49 Billion IDR | -47.84% |
| 2021 Q4 | 498.18 Billion IDR | 8.83% |
| 2021 Q1 | 332.04 Billion IDR | -9.03% |
| 2021 Q2 | 288.69 Billion IDR | -13.05% |
| 2021 Q3 | 457.76 Billion IDR | 58.56% |
| 2021 FY | 1576.69 Billion IDR | 36.98% |
| 2020 Q1 | 285.81 Billion IDR | -2.57% |
| 2020 Q3 | 278.44 Billion IDR | 25.55% |
| 2020 Q2 | 221.78 Billion IDR | -22.4% |
| 2020 FY | 1151.02 Billion IDR | 12.38% |
| 2020 Q4 | 364.98 Billion IDR | 31.08% |
| 2019 Q1 | 260.48 Billion IDR | 10.62% |
| 2019 Q4 | 293.34 Billion IDR | 14.47% |
| 2019 Q3 | 256.25 Billion IDR | 19.66% |
| 2019 Q2 | 214.15 Billion IDR | -17.78% |
| 2019 FY | 1024.24 Billion IDR | 24.25% |
| 2018 Q3 | 232.72 Billion IDR | 28.98% |
| 2018 FY | 824.33 Billion IDR | 28.75% |
| 2018 Q4 | 235.47 Billion IDR | 1.18% |
| 2018 Q2 | 180.44 Billion IDR | -14.05% |
| 2018 Q1 | 209.94 Billion IDR | 23.93% |
| 2017 Q2 | 170.12 Billion IDR | 8.46% |
| 2017 Q4 | 169.4 Billion IDR | -9.76% |
| 2017 FY | 640.23 Billion IDR | 11.89% |
| 2017 Q1 | 156.85 Billion IDR | 70.02% |
| 2017 Q3 | 187.72 Billion IDR | 10.35% |
| 2016 Q3 | 128.11 Billion IDR | -36.88% |
| 2016 Q4 | 92.25 Billion IDR | -27.99% |
| 2016 Q2 | 202.97 Billion IDR | 36.35% |
| 2016 FY | 572.19 Billion IDR | 2.13% |
| 2016 Q1 | 148.86 Billion IDR | 6.77% |
| 2015 Q1 | 154.14 Billion IDR | 5.49% |
| 2015 Q3 | 102.84 Billion IDR | -37.22% |
| 2015 Q2 | 163.82 Billion IDR | 6.28% |
| 2015 FY | 560.24 Billion IDR | 2.09% |
| 2015 Q4 | 139.43 Billion IDR | 35.58% |
| 2014 Q1 | 146.95 Billion IDR | -26.58% |
| 2014 Q3 | -17.58 Billion IDR | -106.43% |
| 2014 Q2 | 273.27 Billion IDR | 85.96% |
| 2014 Q4 | 146.12 Billion IDR | 930.96% |
| 2014 FY | 548.77 Billion IDR | -15.61% |
| 2013 Q4 | 200.14 Billion IDR | 0.3% |
| 2013 FY | 650.28 Billion IDR | 27.09% |
| 2013 Q2 | 150.2 Billion IDR | 49.64% |
| 2013 Q3 | 199.55 Billion IDR | 32.85% |
| 2013 Q1 | 100.37 Billion IDR | 0.0% |
| 2012 FY | 511.68 Billion IDR | 12.95% |
| 2011 FY | 453.01 Billion IDR | 32.09% |
| 2010 FY | 342.96 Billion IDR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 190.05 Billion IDR | -526.609% |
| PT Merck Tbk | 199.72 Billion IDR | -496.242% |
| PT Phapros, Tbk | 71.32 Billion IDR | -1569.74% |
| PT Pyridam Farma Tbk | 1.87 Billion IDR | -63261.352% |
| PT Tempo Scan Pacific Tbk | 1257.95 Billion IDR | 5.333% |